Polihexanide
Approved · EMAAlso known as Polyhexanide, POLYHEXAMETHYLENE BIGUANIDE, Poly(hexamethylene biguanide).
Recent clinical, regulatory, research and industry developments relating to this drug.
Parasitic Ulcer Treatment Trial
Antimicrobial Activity of Two Mouthwashes
Efficacy of Intraoperative Surgical Scrubbing in Reducing Bacterial Load After Nail Removal Surgery
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Indication: Akantior is indicated for the treatment of Acanthamoeba keratitis in adults and children from 12 years of age.
Evidence ↗Contains information from the European Medicines Agency (European Medicines Agency), © EMA, reused under CC BY 4.0.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Antimicrobial Activity of Two Mouthwashes
- RxNorm (U.S. National Library of Medicine) — drug identity
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.